|Return to Archived Newletter Index
|Vol. 5 Issue 5
IN THIS ISSUE:
Aortic stent graft patent acquired.
Experiments with porcine cells begin.
Re-cap of Australian Endovascular Conference.
Catalog number system TALENT".
Worldmed Begins Experiments Utilizing Porcine Endothelial and Smooth Muscle Cells to Seed Thin Wall Graft Materials.
In cooperation with Worldmed Labcor and Labcor Laboratories of Brazil, Worldmed has begun a series of experiments utilizing a combination of fibrin glue, gioloma growth factor, porcine endothelial cells and porcine smooth muscle cells to improve the healing and long term durability characteristics of endovascular grafts. The company believes there is great potential for improved patency in smaller vessels compared to currently available technologies.
Worldmed Acquires Key 1984 Filed Patent For Bifurcated Aortic Stent Graft System!
World Medical Manufacturing Corp-oration has been assigned U.S. Patent No. 4,562.596 "Aortic Graft Device and Method for performing an Intraluminal Abdominal Aortic Aneurysm Repair" filed April 1984, Issued Jan. 7, 1985 from Dr. Elliot Kornberg. This patent is a fundamental early art patent in the field covering the following concepts and designs:
TALENT" Clinical Results Presented at a Number of Scientific Conferences
Brooklyn Endovascular Conference
International Symposium of Vascular Diagnosis and Intervention
10th Intl. Congress Endovascular Interventions
|TOP OF PAGE | NEXT PAGE